You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

List of Excipients in API tolterodine tartrate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing tolterodine tartrate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
PHARMACIA & UPJOHN COMPANY LLC DETROL tolterodine tartrate 0009-4541 CELLULOSE, MICROCRYSTALLINE
PHARMACIA & UPJOHN COMPANY LLC DETROL tolterodine tartrate 0009-4541 HYPROMELLOSE
PHARMACIA & UPJOHN COMPANY LLC DETROL tolterodine tartrate 0009-4541 MAGNESIUM STEARATE
PHARMACIA & UPJOHN COMPANY LLC DETROL tolterodine tartrate 0009-4541 SILICON DIOXIDE
PHARMACIA & UPJOHN COMPANY LLC DETROL tolterodine tartrate 0009-4541 STEARIC ACID
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing tolterodine tartrate

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc tolterodine tartrate 0093-0010 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc tolterodine tartrate 0093-0010 CROSCARMELLOSE SODIUM
Teva Pharmaceuticals USA Inc tolterodine tartrate 0093-0010 HYPROMELLOSE 2910
Teva Pharmaceuticals USA Inc tolterodine tartrate 0093-0010 LACTOSE MONOHYDRATE
Teva Pharmaceuticals USA Inc tolterodine tartrate 0093-0010 POLYETHYLENE GLYCOL 6000
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for tolterodine tartrate

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DIBUTYL SEBACATE

Excipient focus: DIMETHICONE

Excipient focus: ETHYL ACRYLATE

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C GREEN NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSE PHTHALATE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYL METHACRYLATE

Excipient focus: METHYLENE CHLORIDE

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: OLEIC ACID

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group